No serious safety concerns with early drug approval

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2011年 / 1354卷 / 1期

关键词：

Public Health; Standard Procedure; Healthcare Professional; Safety Concern; Safety Issue;

D O I：

10.2165/00128415-201113540-00007

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] Safety concerns slow new drug review and approval processes
Wechsler, Jill
[J]. FORMULARY, 2009, 44 (11) : 341 - 342
[2] FDA approval of umbralisib withdrawn due to safety concerns
[J]. Reactions Weekly, 2022, 1910 (1) : 2 - 2
[3] PRR Computations Over Time Continue to Reveal Serious Safety Signals Aoon After Drug Approval
Altman, Keith L.
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 405 - 405
[4] Concerns on safety of drug are unwarranted
Lessell, S
[J]. BRITISH MEDICAL JOURNAL, 1998, 316 (7124): : 67 - 67
[5] Faster drug approval: challenges for safety
Preziosi, Paolo
[J]. EXPERT OPINION ON DRUG SAFETY, 2016, 15 (09) : 1205 - 1218
[6] THE SAFETY AND EFFICACY OF NEW DRUG APPROVAL
GIERINGER, DH
[J]. CATO JOURNAL, 1985, 5 (01) : 177 - 201
[7] Speed and Safety in Drug Approval and Commercialization
Unguru, Yoram
[J]. PEDIATRICS, 2017, 140 (05)
[8] Diet drug approval is delayed because of breast cancer concerns
White, K
[J]. JOURNAL OF WOMENS HEALTH, 1998, 7 (04) : 404 - 405
[9] SAFETY CONCERNS OVER AN OSTEOPOROSIS DRUG
Aschenbrenner, Diane S.
[J]. AMERICAN JOURNAL OF NURSING, 2011, 111 (11) : 23 - 24
[10] Safety Evaluation for New Drug Approval in Korea
Young-Ok Kim
Kwang-Won Ha
Kwang-Sik Choi
[J]. Drug information journal : DIJ / Drug Information Association, 2001, 35 (1): : 285 - 291

← 1 2 3 4 5 →